▟ Vinebot intrinsic value, daily

← back

MTD Mettler Toledo

pharma · valued with glm-5.2 medium conviction · deep-dived 2026-09-17

HOLD
Intrinsic value$568.53
Price (at call)$1,378.69
Margin of safety -58.8%
vs market (rating basis) -8.7%

Model unavailable; showing baseline valuation.

⚠ LLM error: empty response; using baseline

The story

Value drivers

Revenue growth (Y1)3.0%
Terminal growth3.5%
Forecast horizon10y
Target operating margin28.2%
Years to target margin5
Sales-to-capital1.94
Beta1.22
Failure probability0.0%
Cost of capital (WACC)10.1%
Terminal WACC9.2%

Valuation bridge

PV of explicit FCFF6.40B
PV of terminal value7.08B
Equity value11.39B
÷ shares → per share$568.53

News

neutral -0.10 · 8 articles

  • What Makes Mettler-Toledo International (MTD) an Attractive Bet?
  • 2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds
  • Is Mettler-Toledo Stock Underperforming the Nasdaq?
  • Research Tools & Consumables Stocks Q2 Teardown: Mettler-Toledo (NYSE:MTD) Vs The Rest
  • Redburn starts Mettler-Toledo at Sell, sees valuation outpacing growth
  • Do Wall Street Analysts Like Mettler-Toledo Stock?
  • Mettler-Toledo (MTD) Upgraded to Buy: Here's Why
  • 1 Healthcare Stock to Target This Week and 2 Facing Headwinds

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 4.26B 3.0% 28.2% 995.81M 63.86M 931.95M 846.25M
2 4.39B 3.1% 28.2% 1.03B 66.99M 959.25M 790.94M
3 4.52B 3.1% 28.2% 1.06B 70.29M 987.87M 739.64M
4 4.67B 3.2% 28.2% 1.09B 73.77M 1.02B 692.04M
5 4.82B 3.2% 28.2% 1.13B 77.44M 1.05B 647.85M
6 4.98B 3.3% 28.2% 1.16B 81.32M 1.08B 606.81M
7 5.14B 3.3% 28.2% 1.20B 85.41M 1.12B 568.67M
8 5.32B 3.4% 28.2% 1.24B 89.72M 1.15B 533.22M
9 5.50B 3.4% 28.2% 1.29B 94.29M 1.19B 500.25M
10 5.69B 3.5% 28.2% 1.33B 99.11M 1.23B 469.56M

History

DatePriceIntrinsicMoSRating
2026-09-17$1,378.69 $568.53 -58.8% HOLD
2026-08-17$1,419.02 $599.40 -57.8% HOLD
2026-07-14$1,299.53 $585.45 -54.9% HOLD
2026-06-23$1,156.64 $601.89 -48.0% HOLD